U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides and fungicides as they plan for spring planting next year, which market analysts said could hit the bottom lines of agrichemical companies like Bayer.
Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers
Bayer’s shares sink to 20-year low on 2025 earnings fall forecast
Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company's shares and piling pressure on its CEO to deliver on his turnaround efforts.
Bayer to acquire HyTech canola facility
Bayer CropScience Inc. announced on Oct. 3 it will purchase the HyTech canola treating and packaging plant near Coaldale, Alta. with the sale to be made final on Nov. 1.
Bayer, others defeat US farmers’ chemical price-fixing lawsuit
A U.S. judge has dismissed a lawsuit accusing agriculture giants Bayer, Corteva, Syngenta and others of conspiring with wholesalers and retail outlets to fix prices for seeds and crop protection chemicals, causing farmers to pay higher prices
Bayer launches VT4PRO at Canada’s Outdoor Farm Show 2024
Bayer CropScience is bringing a new weapon to the fight against corn rootworm and other yield-robbing insects, VT4PRO.
BASF to close two glufosinate production sites
BASF plans to shut down two sites in Germany that are part of its production network for the glufosinate-ammonium weed killer, the German chemicals group said on Wednesday.
Bayer looks to AI to combat herbicide resistance faster
Bayer's Icafolin will be its first new mode of action herbicide in some 30 years when it launches in 2028
Weeds are growing resistant to the herbicides already on the market, and agribusiness companies like Bayer are in a desperate search for new modes of action to help farmers kill them.
Former Manitoba man sues Bayer for causing his cancer
A Calgary man who lived on a farm in Carman, Man., as a child has filed a lawsuit saying chemicals he was exposed to resulted in a cancer diagnosis. The plaintiffs in the case are Kevin Giesbrecht and his common-law spouse, Jennifer McAlpine, who now live in Calgary. According to court documents, Giesbrecht lived on […] Read more
Bayer investor Deka takes a stand against CEO in annual vote
Bayer shareholder Deka Investment said on Friday it would not join other large investors in supporting the healthcare and agriculture group's management at its annual general meeting.
Bayer confirms 2024 outlook despite slow start for agriculture, consumer health units
Bayer confirmed its full-year forecast for earnings and cash flow on Monday despite slow business at its crop science and consumer health divisions.
Cyber-Savvy Farmer
